Monosomal and complex karyotypes as prognostic parameters in patients with International Prognostic Scoring System higher risk myelodysplastic syndrome treated with azacitidine

BACKGROUND: Azacitidine (AZA) is standard care for patients with myelodysplastic syndrome (MDS) who have not had allogeneic stem cell transplantation. Chromosomal abnormalities (CA) including complex karyotype (CK) or monosomal karyotype (MK) are associated with clinical outcome in patients with MDS...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Kyung-Lim, Song, Moo-Kon, Shin, Ho-Jin, Na, Hae-Jung, Shin, Dong-Hun, Kim, Joong-Keun, Moon, Joon-Ho, Ahn, Jae-Sook, Song, Ik-Chan, Hong, Junshik, Lee, Gyeong-won, Chung, Joo-Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278004/
https://www.ncbi.nlm.nih.gov/pubmed/25548756
http://dx.doi.org/10.5045/br.2014.49.4.234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278004/
https://www.ncbi.nlm.nih.gov/pubmed/25548756
http://dx.doi.org/10.5045/br.2014.49.4.234

Ejemplares similares